Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

Comorbidities in patients with non-functioning pituitary adenoma: influence of long-term growth hormone replacement

Hammarstrand C, Ragnarsson O, Bengtsson O, Bryngelsson IL, Johannsson G, Olsson DS.

Eur J Endocrinol. 2018 Oct 1;179(4):229-237. doi: 10.1530/EJE-18-0370.

PMID:
30299891
2.

Comorbidities in patients with non-functioning pituitary adenoma: influence of long-term growth hormone replacement.

Hammarstrand C, Ragnarsson O, Bengtsson O, Bryngelsson IL, Johannsson G, Olsson DS.

Eur J Endocrinol. 2018 Jul 26. pii: EJE-18-0370. doi: 10.1530/EJE-18-0370. [Epub ahead of print]

PMID:
30049813
3.

Prevalence and treatment of central hypogonadism and hypoandrogenism in women with hypopituitarism.

Olivius C, Landin-Wilhelmsen K, Olsson DS, Johannsson G, Tivesten Å.

Pituitary. 2018 Oct;21(5):445-453. doi: 10.1007/s11102-018-0895-1.

PMID:
29789996
4.

Biomarkers of GH action in children and adults.

Schilbach K, Olsson DS, Boguszewski MCS, Bidlingmaier M, Johannsson G, Jørgensen JL.

Growth Horm IGF Res. 2018 Jun;40:1-8. doi: 10.1016/j.ghir.2018.03.005. Epub 2018 Mar 20. Review.

PMID:
29601998
5.

Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial.

Johannsson G, Feldt-Rasmussen U, Håkonsson IH, Biering H, Rodien P, Tahara S, Toogood A, Rasmussen MH; REAL 2 Study Group.

Eur J Endocrinol. 2018 May;178(5):491-499. doi: 10.1530/EJE-17-1073. Epub 2018 Mar 2.

6.

Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study.

Esposito D, Ragnarsson O, Granfeldt D, Marlow T, Johannsson G, Olsson DS.

Eur J Endocrinol. 2018 May;178(5):459-469. doi: 10.1530/EJE-18-0015. Epub 2018 Feb 26.

PMID:
29483205
7.

Growth Hormone Research Society perspective on biomarkers of GH action in children and adults.

Johannsson G, Bidlingmaier M, Biller BMK, Boguszewski M, Casanueva FF, Chanson P, Clayton PE, Choong CS, Clemmons D, Dattani M, Frystyk J, Ho K, Hoffman AR, Horikawa R, Juul A, Kopchick JJ, Luo X, Neggers S, Netchine I, Olsson DS, Radovick S, Rosenfeld R, Ross RJ, Schilbach K, Solberg P, Strasburger C, Trainer P, Yuen KCJ, Wickstrom K, Jorgensen JOL; Growth Hormone Research Society.

Endocr Connect. 2018 Mar;7(3):R126-R134. doi: 10.1530/EC-18-0047. Epub 2018 Feb 26. Review.

8.

Primary aldosteronism and thyroid disorders in atrial fibrillation: A Swedish nationwide case-control study.

Mourtzinis G, Adamsson Eryd S, Rosengren A, Björck L, Adiels M, Johannsson G, Manhem K.

Eur J Prev Cardiol. 2018 May;25(7):694-701. doi: 10.1177/2047487318759853. Epub 2018 Feb 23.

PMID:
29473461
9.

Adrenal venous sampling: the learning curve of a single interventionalist with 282 consecutive procedures.

Jakobsson H, Farmaki K, Sakinis A, Ehn O, Johannsson G, Ragnarsson O.

Diagn Interv Radiol. 2018 Mar-Apr;24(2):89-93. doi: 10.5152/dir.2018.17397.

10.

Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016.

McCormack A, Dekkers OM, Petersenn S, Popovic V, Trouillas J, Raverot G, Burman P; ESE survey collaborators.

Eur J Endocrinol. 2018 Mar;178(3):265-276. doi: 10.1530/EJE-17-0933. Epub 2018 Jan 12.

PMID:
29330228
11.

Pseudoacromegaly: A Differential Diagnostic Problem for Acromegaly With a Genetic Solution.

Dahlqvist P, Spencer R, Marques P, Dang MN, Glad CAM, Johannsson G, Korbonits M.

J Endocr Soc. 2017 Jul 14;1(8):1104-1109. doi: 10.1210/js.2017-00164. eCollection 2017 Aug 1.

12.

Health Care Burden in Patients With Adrenal Insufficiency.

Gunnarsson C, Ryan MP, Marelli C, Baker ER, Stewart PM, Johannsson G, Biller BMK.

J Endocr Soc. 2017 Apr 12;1(5):512-523. doi: 10.1210/js.2016-1064. eCollection 2017 May 1.

13.

Turning back the clock on adrenal insufficiency.

Johannsson G.

Lancet Diabetes Endocrinol. 2018 Mar;6(3):158-159. doi: 10.1016/S2213-8587(17)30431-X. Epub 2017 Dec 8. No abstract available.

PMID:
29229496
14.

Primary Adrenal Insufficiency: Managing Mineralocorticoid Replacement Therapy.

Esposito D, Pasquali D, Johannsson G.

J Clin Endocrinol Metab. 2018 Feb 1;103(2):376-387. doi: 10.1210/jc.2017-01928. Review.

PMID:
29156052
15.

Cytokine Autoantibody Screening in the Swedish Addison Registry Identifies Patients With Undiagnosed APS1.

Eriksson D, Dalin F, Eriksson GN, Landegren N, Bianchi M, Hallgren Å, Dahlqvist P, Wahlberg J, Ekwall O, Winqvist O, Catrina SB, Rönnelid J; Swedish Addison Registry Study Group, Hulting AL, Lindblad-Toh K, Alimohammadi M, Husebye ES, Knappskog PM, Rosengren Pielberg G, Bensing S, Kämpe O.

J Clin Endocrinol Metab. 2018 Jan 1;103(1):179-186. doi: 10.1210/jc.2017-01957.

PMID:
29069385
16.

Incidence, prevalence and seasonal onset variation of Addison's disease among persons with type 1 diabetes mellitus: nationwide, matched cohort studies.

Chantzichristos D, Persson A, Eliasson B, Miftaraj M, Franzén S, Svensson AM, Johannsson G.

Eur J Endocrinol. 2018 Jan;178(1):115-122. doi: 10.1530/EJE-17-0751. Epub 2017 Oct 24.

PMID:
29066573
17.

Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study.

Wijnen M, Olsson DS, van den Heuvel-Eibrink MM, Hammarstrand C, Janssen JAMJL, van der Lely AJ, Johannsson G, Neggers SJCMM.

Eur J Endocrinol. 2018 Jan;178(1):95-104. doi: 10.1530/EJE-17-0707. Epub 2017 Oct 18.

PMID:
29046325
18.

Visceral Fat and Novel Biomarkers of Cardiovascular Disease in Patients With Addison's Disease: A Case-Control Study.

Bergthorsdottir R, Ragnarsson O, Skrtic S, Glad CAM, Nilsson S, Ross IL, Leonsson-Zachrisson M, Johannsson G.

J Clin Endocrinol Metab. 2017 Nov 1;102(11):4264-4272. doi: 10.1210/jc.2017-01324.

PMID:
28945861
19.

Aldosterone to Renin Ratio as a Screening Instrument for Primary Aldosteronism in a Middle-Aged Population with Atrial Fibrillation.

Mourtzinis G, Ebrahimi A, Gustafsson H, Johannsson G, Manhem K.

Horm Metab Res. 2017 Nov;49(11):831-837. doi: 10.1055/s-0043-119220. Epub 2017 Sep 21.

PMID:
28934817
20.

MECHANISMS IN ENDOCRINOLOGY: Clinical and pharmacogenetic aspects of the growth hormone receptor polymorphism.

Boguszewski CL, Barbosa EJL, Svensson PA, Johannsson G, Glad CAM.

Eur J Endocrinol. 2017 Dec;177(6):R309-R321. doi: 10.1530/EJE-17-0549. Epub 2017 Sep 13. Review.

PMID:
28904008
21.

Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement.

Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS, Melmed S, Mortini P, Wass J, Giustina A; Pituitary Society, Expert Group on Pituitary Tumors.

Pituitary. 2017 Oct;20(5):489-498. doi: 10.1007/s11102-017-0838-2. Erratum in: Pituitary. 2018 Sep 20;:.

22.

The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up.

Wijnen M, Olsson DS, van den Heuvel-Eibrink MM, Hammarstrand C, Janssen JAMJL, van der Lely AJ, Johannsson G, Neggers SJCMM.

Eur J Endocrinol. 2018 Jan;178(1):11-22. doi: 10.1530/EJE-17-0387. Epub 2017 Sep 7.

PMID:
28882980
23.

The impact of adjustments to the diagnostic criteria for biochemical remission in surgically treated patients with acromegaly.

Kousoula K, Farmaki K, Skoglund T, Olsson DS, Johannsson G, Trimpou P, Ragnarsson O.

Growth Horm IGF Res. 2017 Oct;36:16-21. doi: 10.1016/j.ghir.2017.08.003. Epub 2017 Aug 24.

PMID:
28846862
24.

Meeting Reports: The 25th Anniversary of the Growth Hormone Research Society Lisbon, Portugal, May 20, 2017.

Kopchick JJ, Johannsson G.

Pediatr Endocrinol Rev. 2017 Sep;15(1):53-56. doi: 10.17458/per.vol15.2017.kj.mr.25anniversaryghsociety. No abstract available.

PMID:
28845628
25.

A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing's syndrome.

Valassi E, Aulinas A, Glad CA, Johannsson G, Ragnarsson O, Webb SM.

Clin Endocrinol (Oxf). 2017 Nov;87(5):433-439. doi: 10.1111/cen.13414. Epub 2017 Jul 31.

PMID:
28665508
26.

Higher glucocorticoid replacement doses are associated with increased mortality in patients with pituitary adenoma.

Hammarstrand C, Ragnarsson O, Hallén T, Andersson E, Skoglund T, Nilsson AG, Johannsson G, Olsson DS.

Eur J Endocrinol. 2017 Sep;177(3):251-256. doi: 10.1530/EJE-17-0340. Epub 2017 Jun 8.

PMID:
28596421
27.

Muscle strength in patients with acromegaly at diagnosis and during long-term follow-up.

Füchtbauer L, Olsson DS, Bengtsson BÅ, Norrman LL, Sunnerhagen KS, Johannsson G.

Eur J Endocrinol. 2017 Aug;177(2):217-226. doi: 10.1530/EJE-17-0120. Epub 2017 May 31.

PMID:
28566445
28.

Decreased prefrontal functional brain response during memory testing in women with Cushing's syndrome in remission.

Ragnarsson O, Stomby A, Dahlqvist P, Evang JA, Ryberg M, Olsson T, Bollerslev J, Nyberg L, Johannsson G.

Psychoneuroendocrinology. 2017 Aug;82:117-125. doi: 10.1016/j.psyneuen.2017.05.010. Epub 2017 May 12.

PMID:
28544904
29.

Prevalence of primary aldosteronism among patients with type 2 diabetes.

Tancredi M, Johannsson G, Eliasson B, Eggertsen R, Lindblad U, Dahlqvist S, Imberg H, Lind M.

Clin Endocrinol (Oxf). 2017 Sep;87(3):233-241. doi: 10.1111/cen.13370. Epub 2017 Jun 21.

PMID:
28493291
30.

Reduced DNA methylation and psychopathology following endogenous hypercortisolism - a genome-wide study.

Glad CA, Andersson-Assarsson JC, Berglund P, Bergthorsdottir R, Ragnarsson O, Johannsson G.

Sci Rep. 2017 Mar 16;7:44445. doi: 10.1038/srep44445.

31.

Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study.

Nilsson AG, Bergthorsdottir R, Burman P, Dahlqvist P, Ekman B, Engström BE, Ragnarsson O, Skrtic S, Wahlberg J, Achenbach H, Uddin S, Marelli C, Johannsson G.

Eur J Endocrinol. 2017 Jun;176(6):715-725. doi: 10.1530/EJE-17-0067. Epub 2017 Mar 14.

32.

Incidence of malignant tumours in patients with a non-functioning pituitary adenoma.

Olsson DS, Hammarstrand C, Bryngelsson IL, Nilsson AG, Andersson E, Johannsson G, Ragnarsson O.

Endocr Relat Cancer. 2017 May;24(5):227-235. doi: 10.1530/ERC-16-0518. Epub 2017 Mar 8.

PMID:
28274953
33.

Comorbidities, treatment patterns and cost-of-illness of acromegaly in Sweden: a register-linkage population-based study.

Lesén E, Granfeldt D, Houchard A, Dinet J, Berthon A, Olsson DS, Björholt I, Johannsson G.

Eur J Endocrinol. 2017 Feb;176(2):203-212. Epub 2016 Nov 15.

PMID:
27932528
34.

Mortality in patients with diabetes mellitus and Addison's disease: a nationwide, matched, observational cohort study.

Chantzichristos D, Persson A, Eliasson B, Miftaraj M, Franzén S, Bergthorsdottir R, Gudbjörnsdottir S, Svensson AM, Johannsson G.

Eur J Endocrinol. 2017 Jan;176(1):31-39.

PMID:
27928991
35.

Clinical and Immunological Characteristics of Autoimmune Addison Disease: A Nationwide Swedish Multicenter Study.

Dalin F, Nordling Eriksson G, Dahlqvist P, Hallgren Å, Wahlberg J, Ekwall O, Söderberg S, Rönnelid J, Olcén P, Winqvist O, Catrina SB, Kriström B, Laudius M, Isaksson M, Halldin Stenlid M, Gustafsson J, Gebre-Medhin G, Björnsdottir S, Janson A, Åkerman AK, Åman J, Duchen K, Bergthorsdottir R, Johannsson G, Lindskog E, Landin-Olsson M, Elfving M, Waldenström E, Hulting AL, Kämpe O, Bensing S.

J Clin Endocrinol Metab. 2017 Feb 1;102(2):379-389. doi: 10.1210/jc.2016-2522.

PMID:
27870550
36.

Bridging the gap: metabolic and endocrine care of patients during transition.

Hokken-Koelega A, van der Lely AJ, Hauffa B, Häusler G, Johannsson G, Maghnie M, Argente J, DeSchepper J, Gleeson H, Gregory JW, Höybye C, Keleştimur F, Luger A, Müller HL, Neggers S, Popovic-Brkic V, Porcu E, Sävendahl L, Shalet S, Spiliotis B, Tauber M.

Endocr Connect. 2016 Nov;5(6):R44-R54. Epub 2016 Nov 1. Review.

37.

Seven years of growth hormone (GH) replacement improves quality of life in hypopituitary patients with adult-onset GH deficiency.

Elbornsson M, Horvath A, Götherström G, Bengtsson BÅ, Johannsson G, Svensson J.

Eur J Endocrinol. 2017 Feb;176(2):99-109. Epub 2016 Nov 1.

PMID:
27803031
38.

Life expectancy in patients with pituitary adenoma receiving growth hormone replacement.

Olsson DS, Trimpou P, Hallén T, Bryngelsson IL, Andersson E, Skoglund T, Bengtsson BÅ, Johannsson G, Nilsson AG.

Eur J Endocrinol. 2017 Jan;176(1):67-75. Epub 2016 Oct 21.

PMID:
27770012
39.

Exploring Inpatient Hospitalizations and Morbidity in Patients With Adrenal Insufficiency.

Stewart PM, Biller BM, Marelli C, Gunnarsson C, Ryan MP, Johannsson G.

J Clin Endocrinol Metab. 2016 Dec;101(12):4843-4850. Epub 2016 Sep 13.

PMID:
27623069
40.

Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.

Johannsson G, Lennernäs H, Marelli C, Rockich K, Skrtic S.

Eur J Endocrinol. 2016 Jul;175(1):85-93. doi: 10.1530/EJE-15-1212. Epub 2016 Apr 29.

41.

Improving glucocorticoid replacement in patients with adrenal insufficiency.

Johannsson G.

Endocrine. 2016 Jun;52(3):405-7. doi: 10.1007/s12020-016-0929-2. Epub 2016 Apr 4. No abstract available.

PMID:
27041094
42.

Hypopituitarism.

Higham CE, Johannsson G, Shalet SM.

Lancet. 2016 Nov 12;388(10058):2403-2415. doi: 10.1016/S0140-6736(16)30053-8. Epub 2016 Mar 31. Review.

PMID:
27041067
43.

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations.

Christiansen JS, Backeljauw PF, Bidlingmaier M, Biller BM, Boguszewski MC, Casanueva FF, Chanson P, Chatelain P, Choong CS, Clemmons DR, Cohen LE, Cohen P, Frystyk J, Grimberg A, Hasegawa Y, Haymond MW, Ho K, Hoffman AR, Holly JM, Horikawa R, Höybye C, Jorgensen JO, Johannsson G, Juul A, Katznelson L, Kopchick JJ, Lee KO, Lee KW, Luo X, Melmed S, Miller BS, Misra M, Popovic V, Rosenfeld RG, Ross J, Ross RJ, Saenger P, Strasburger CJ, Thorner MO, Werner H, Yuen K.

Eur J Endocrinol. 2016 Jun;174(6):C1-8. doi: 10.1530/EJE-16-0111. Epub 2016 Mar 23.

44.

[Primary aldosteronism is an underdiagnosed cause of hypertension. Important to find undiagnosed patients--effective treatment available].

Ragnarsson O, Muth A, Johannsson G, Wängberg B.

Lakartidningen. 2015 Dec 1;112. pii: DRFR. Review. Swedish.

45.

Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion.

Verbalis JG, Greenberg A, Burst V, Haymann JP, Johannsson G, Peri A, Poch E, Chiodo JA 3rd, Dave J.

Am J Med. 2016 May;129(5):537.e9-537.e23. doi: 10.1016/j.amjmed.2015.11.005. Epub 2015 Nov 14.

PMID:
26584969
46.

[The importance of adrenal vein sampling in primary aldosteronism. Necessary examination for many patients as computed tomography can lead to errors].

Ragnarsson O, Wängberg B, Muth A, Sakinis A, Johannsson G.

Lakartidningen. 2015 Feb 10;112. pii: C97U. Swedish.

47.

Proposal of a clinical response score and predictors of clinical response to 2 years of GH replacement therapy in adult GH deficiency.

Schneider HJ, Buchfelder M, Wallaschofski H, Luger A, Johannsson G, Kann PH, Mattsson A.

Eur J Endocrinol. 2015 Dec;173(6):843-51. doi: 10.1530/EJE-15-0305. Epub 2015 Sep 14.

PMID:
26369579
48.

Mean Expected Error in Prediction of Total Body Water: A True Accuracy Comparison between Bioimpedance Spectroscopy and Single Frequency Regression Equations.

Seoane F, Abtahi S, Abtahi F, Ellegård L, Johannsson G, Bosaeus I, Ward LC.

Biomed Res Int. 2015;2015:656323. doi: 10.1155/2015/656323. Epub 2015 Jun 2.

49.

Reviewing the safety of GH replacement therapy in adults.

Stochholm K, Johannsson G.

Growth Horm IGF Res. 2015 Aug;25(4):149-57. doi: 10.1016/j.ghir.2015.06.006. Epub 2015 Jun 19. Review.

PMID:
26117668
50.

Excess Mortality in Women and Young Adults With Nonfunctioning Pituitary Adenoma: A Swedish Nationwide Study.

Olsson DS, Nilsson AG, Bryngelsson IL, Trimpou P, Johannsson G, Andersson E.

J Clin Endocrinol Metab. 2015 Jul;100(7):2651-8. doi: 10.1210/jc.2015-1475. Epub 2015 May 6.

PMID:
25946030

Supplemental Content

Loading ...
Support Center